Brief: Pds Biotech Reports Q3 Financial Results, Provides Business Update
14/11/2022 17:24
Nov 14 (Reuters) - Pds Biotechnology Corp PDSB.O :
* PDS BIOTECH REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* NET LOSS FOR THREE MONTHS ENDED SEPTEMBER 30, 2022 WAS
APPROXIMATELY $7.4 MILLION, OR $0.26 PER BASIC SHARE AND DILUTED
SHARE
* Q3 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA
* QTRLY BASIC AND DILUTED LOSS PER SHARE $ 0.26
Source text for Eikon: ID:nGNXbb6cL8
Further company coverage: PDSB.O
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing